Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esbriet
Biotech
PureTech's deupirfenidone shows durable effect in IPF study
PureTech presented results of an open-label extension study of itsidiopathic pulmonary fibrosis candidate deupirfenidone, showing its durability.
Kevin Dunleavy
May 20, 2025 5:15pm
PureTech's lung fibrosis drug slows decline in phase 2 trial
Dec 16, 2024 7:00am
BMS charts 2nd pulmonary fibrosis win with LPA1 antagonist
Sep 11, 2023 10:05am
A drug may already exist to counter heart risk in older men
Jul 14, 2022 2:00pm
Kadmon clinical POC data raise expectations for IPF drug
Feb 13, 2018 9:06am
Roche in part-sale of mixed bag lebrikizumab to Dermira
Aug 8, 2017 9:22am
